UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (86) 86
life sciences & biomedicine (84) 84
humans (77) 77
oncology (77) 77
middle aged (63) 63
female (59) 59
adult (57) 57
male (55) 55
aged (51) 51
cancer (45) 45
tumors (42) 42
biological and medical sciences (39) 39
medical sciences (39) 39
treatment outcome (33) 33
hematology, oncology and palliative medicine (32) 32
research (32) 32
pharmacology. drug treatments (30) 30
chemotherapy (27) 27
oncology, experimental (27) 27
disease-free survival (26) 26
metastasis (26) 26
clinical trials (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
sarcoma (22) 22
sarcoma - drug therapy (21) 21
antineoplastic agents (19) 19
care and treatment (19) 19
adolescent (18) 18
prognosis (17) 17
young adult (17) 17
aged, 80 and over (16) 16
drug therapy (16) 16
soft tissue sarcoma (16) 16
antineoplastic agents - therapeutic use (15) 15
survival (15) 15
drug administration schedule (14) 14
kaplan-meier estimate (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
analysis (12) 12
europe (12) 12
physics (12) 12
antineoplastic agents - administration & dosage (11) 11
maximum tolerated dose (11) 11
sarcoma - mortality (11) 11
soft tissue neoplasms - drug therapy (11) 11
dose-response relationship, drug (10) 10
metastases (10) 10
neoplasm staging (10) 10
patients (10) 10
follow-up studies (9) 9
soft tissue neoplasms - mortality (9) 9
survival rate (9) 9
anthracyclines (8) 8
breast cancer (8) 8
dermatology (8) 8
disease progression (8) 8
doxorubicin (8) 8
neoplasms - drug therapy (8) 8
pazopanib (8) 8
protein kinase inhibitors - therapeutic use (8) 8
pyrimidines - therapeutic use (8) 8
retrospective studies (8) 8
sarcoma - pathology (8) 8
sulfonamides - therapeutic use (8) 8
time factors (8) 8
antimitotic agents (7) 7
antineoplastic agents - adverse effects (7) 7
cancer research (7) 7
confidence intervals (7) 7
neoplasm metastasis (7) 7
product development (7) 7
proportional hazards models (7) 7
prospective studies (7) 7
risk factors (7) 7
survival analysis (7) 7
tumors of the skin and soft tissue. premalignant lesions (7) 7
angiogenesis inhibitors - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - pharmacokinetics (6) 6
breast neoplasms - drug therapy (6) 6
crizotinib (6) 6
deoxycytidine - administration & dosage (6) 6
deoxycytidine - analogs & derivatives (6) 6
doxorubicin - administration & dosage (6) 6
electric circuits or apparatus specially designed for use inequipment for killing, stunning, or guiding living beings (6) 6
electric techniques not otherwise provided for (6) 6
electricity (6) 6
measuring (6) 6
measuring electric variables (6) 6
measuring magnetic variables (6) 6
medical research (6) 6
progression-free survival (6) 6
soft tissue neoplasms - pathology (6) 6
testing (6) 6
alarm systems (5) 5
breast neoplasms - pathology (5) 5
cancer patients (5) 5
chemotherapy, adjuvant (5) 5
cisplatin (5) 5
cisplatin - administration & dosage (5) 5
dosage and administration (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 415 - 423
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1879 - 1886
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1045 - 1054
Journal Article
Journal Article
European urology, ISSN 0302-2838, 2012, Volume 63, Issue 3, pp. 462 - 472
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
Journal Article
Journal Article
BMC cancer, ISSN 1471-2407, 05/2019, Volume 19, Issue 1, pp. 494 - 494
REGRESSION | SURGERY | OPEN-LABEL | OXALIPLATIN | DOCETAXEL | BREAST-CANCER | CAPECITABINE | Pertuzumab | NEOADJUVANT CHEMOTHERAPY | Gastro-esophageal junction cancer | Perioperative chemotherapy | HER2 | Gastric cancer | Trastuzumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Male | Antineoplastic Agents - therapeutic use | Young Adult | Fluorouracil - therapeutic use | Netherlands | Antibodies, Monoclonal, Humanized - administration & dosage | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Neoadjuvant Therapy | Republic of Korea | Antibodies, Monoclonal, Humanized - therapeutic use | Trastuzumab - therapeutic use | Esophagogastric Junction - pathology | Treatment Outcome | Trastuzumab - administration & dosage | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Perioperative Period | Cisplatin - therapeutic use | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Progression-Free Survival | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Chemotherapy | Usage | Gastrointestinal cancer | Dosage and administration | Comparative analysis | Drug therapy | Cancer | Immunohistochemistry | Care and treatment | Oncology, Experimental | Gastrointestinal system | Clinical trials | Metastasis | Research | Stomach cancer | Index Medicus
Journal Article